Anthropic's IPO will generate massive capital concentrated among 5,000 employees, enabling thousands of billion-dollar acquisitions to build out the AI ecosystem.

Sam Altman explicitly chose a billion monthly active users over the strongest model, proving distribution is the decisive moat; OpenAI now has both distribution and the strongest…

Anthropic's current ~$50-60B revenue growing at extreme rates justifies a $1T+ valuation at 20x revenue, with potential to double revenue within a year given utility.

SpaceX and Anthropic IPOs will absorb trillions in capital demand; there's ~$1T seeking generative AI exposure that public markets must accommodate.

Microsoft's new in-house models are months behind Anthropic and OpenAI, compute- and talent-starved, and unlikely to catch up due to structural disadvantages versus frontier labs.

Microsoft has specialized for office productivity rather than AGI, lacks the compute scale for massive MoE models, and its Maia chips aren't designed for frontier training.

Microsoft cannot attract top AI researchers like Mark Chen because it lacks the will to win; corporate brand moats don't exist, only people matter.

Nvidia's N1/N1X ARM laptop chips arrive surprisingly late given its dominance; timing may relate to Vera Rubin data center CPU or consumer data acquisition for Jarvis.

Nvidia wants direct consumer data via laptops as a testbed for AI-native OS, positioning for when AI disrupts Apple's ecosystem.

Nvidia now commands majority of TSMC bleeding-edge transistors, giving it distribution leverage over laptop vendors who need frontier-node chips.

New Limit's $435M raise at $3.1B for partial epigenetic reprogramming targeting alcohol-related liver disease represents a tractable path to longevity escape velocity.

Verve-102's single infusion permanently knocks down PCSK9, cutting LDL 62% for 18+ months; combines CRISPR base editing with mRNA delivery to effectively cure atherosclerotic card…